Your browser doesn't support javascript.
Delays in Presentation of New Onset Diabetes at the Start of the COVID-19 Pandemic.
Pillai, Sabitha Sasidharan; Cao, Can; Drees, Cassandra J; Chu, Tzu-Chun; Mason, Katherine; Topor, Lisa Swartz.
  • Pillai SS; Division of Pediatric Endocrinology, Hasbro Children's Hospital, Department of Pediatrics, Hasbro Children's Hospital, The Warren Alpert Medical School of Brown University, Rhode Island Hospital.
  • Cao C; The Warren Alpert Medical School of Brown University.
  • Drees CJ; Department of Pediatrics, Hasbro Children's Hospital, The Warren Alpert Medical School of Brown University, Rhode Island Hospital.
  • Chu TC; Center for Statistical Sciences, Brown University.
  • Mason K; Department of Pediatrics, Hasbro Children's Hospital, The Warren Alpert Medical School of Brown University, Rhode Island Hospital.
  • Topor LS; Division of Pediatric Endocrinology, Hasbro Children's Hospital, Department of Pediatrics, Hasbro Children's Hospital, The Warren Alpert Medical School of Brown University, Rhode Island Hospital.
R I Med J (2013) ; 105(5): 46-50, 2022 Jun 01.
Article in English | MEDLINE | ID: covidwho-1864055
ABSTRACT

OBJECTIVE:

To compare the frequency, severity of presentation and initial presentations of new onset diabetes mellitus (DM) in youth in Rhode Island during the early phase of the COVID-19 pandemic compared to the same time frame in 2018 and 2019.

METHODS:

A retrospective cohort study of youth treated for new onset DM at Hasbro Children's Hospital between March 1 and May 15, 2020, compared to those diagnosed in the same period in 2018 and 2019.

RESULTS:

Fewer youth were diagnosed with new onset DM in Spring 2020 and the percentage of youth with DKA at time of DM diagnosis was higher in Spring 2020 compared to prior years (p=0.048). Age, gender, and DKA complications did not differ by year.

CONCLUSION:

Nearly 50% fewer youth were diagnosed with DM at the start of the COVID-19 pandemic compared to years prior, and those diagnosed with new onset DM in Spring 2020 were more likely to present with DKA. Delays in both initial health care evaluation and the recognition of DM symptoms may have contributed to the decline in overall DM diagnoses and the more severe presentations. Identification of DM symptoms is essential, especially during future surges of COVID-19 or other events that impact the healthcare system, to reduce the risk of DM complications including DKA.
Subject(s)
Keywords
Search on Google
Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Child / Humans Language: English Journal: R I Med J (2013) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adolescent / Child / Humans Language: English Journal: R I Med J (2013) Year: 2022 Document Type: Article